![The association of five preoperative serum tumor markers and pathological features in patients with breast cancer - Lian - 2019 - Journal of Clinical Laboratory Analysis - Wiley Online Library The association of five preoperative serum tumor markers and pathological features in patients with breast cancer - Lian - 2019 - Journal of Clinical Laboratory Analysis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/eb50bb4d-26b0-4192-945d-9f199cb4775b/jcla22875-fig-0002-m.jpg)
The association of five preoperative serum tumor markers and pathological features in patients with breast cancer - Lian - 2019 - Journal of Clinical Laboratory Analysis - Wiley Online Library
![Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction | BMC Cancer | Full Text Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-022-09864-y/MediaObjects/12885_2022_9864_Fig3_HTML.png)
Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction | BMC Cancer | Full Text
![Prolonged Use of Aprepitant in Metastatic Breast Cancer and a Reduction in CA153 Tumour Marker Levels | international journal of cancer and clinical research | clinmed international library Prolonged Use of Aprepitant in Metastatic Breast Cancer and a Reduction in CA153 Tumour Marker Levels | international journal of cancer and clinical research | clinmed international library](https://clinmedjournals.org/images/journal_img/Cancer.jpg)
Prolonged Use of Aprepitant in Metastatic Breast Cancer and a Reduction in CA153 Tumour Marker Levels | international journal of cancer and clinical research | clinmed international library
![Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12282-020-01058-3/MediaObjects/12282_2020_1058_Fig3_HTML.png)
Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink
CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis | PLOS ONE
![Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients](https://www.spandidos-publications.com/article_images/ol/14/6/ol-14-06-7549-g00.jpg)
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
![Hormonal receptor (ER and PgR), Tumor markers (CA15-3 and CEA) status,... | Download Scientific Diagram Hormonal receptor (ER and PgR), Tumor markers (CA15-3 and CEA) status,... | Download Scientific Diagram](https://www.researchgate.net/publication/351385233/figure/tbl1/AS:1024178064994304@1621194487181/Hormonal-receptor-ER-and-PgR-Tumor-markers-CA15-3-and-CEA-status-and-grades-in.png)
Hormonal receptor (ER and PgR), Tumor markers (CA15-3 and CEA) status,... | Download Scientific Diagram
![Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA - Chinese Journal of Cancer Research Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA - Chinese Journal of Cancer Research](http://www.cjcrcn.org/data/pic/3080_7.png)
Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA - Chinese Journal of Cancer Research
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
![Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction | BMC Cancer | Full Text Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-022-09864-y/MediaObjects/12885_2022_9864_Fig4_HTML.png)
Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction | BMC Cancer | Full Text
![The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2020-0015/asset/images/medium/figure1.gif)
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
![Determination of the prognostic value of preoperative CA15‑3 and CEA in predicting the prognosis of young patients with breast cancer Determination of the prognostic value of preoperative CA15‑3 and CEA in predicting the prognosis of young patients with breast cancer](https://www.spandidos-publications.com/article_images/ol/16/4/ol-16-04-4679-g01.jpg)